Genmab — November 2020

[Solsen]

Mosunetuzumab astract i ældre naive DLBCL pts viser 5/11 ude efter uge 3 grundet progression. Lidt svært at dømme pga alder på pts.

[Solsen]

Odronextamab (REGN1979) viser lavere responses i DLBCL og FL end epco stort set samme pts.

[Bulder]

New York lukker skoler. NBI lukker mørkerødt.

[Bulder]

Fra CNBC: Stocks turned sharply lower after Mayor Bill de Blasio announced New York City’s public schools will move to remote learning only as the city tries to tamp down a growing number of coronavirus cases.

[GeorgeBest]

Phase 3 Study of Epcoritamab for Advanced DLBCL to Open in Europe, Australia https://immuno-oncologynews.com/2020/11/18/phase-3-study-epcoritamab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-opening/?cn-reloaded=1

[Helge_LarsenPI-redaktør]

Torsdagens aviser med Tryg, Mærsk og Huscompagniet: https://www.proinvestor.com/investornyt/669735/torsdagens-aviser-med-tryg-maersk-og-huscompagniet

[bibob]

God morgen

[bibob]

Håber at kurserne bliver bedre end vejret her i Sæby i dag.

[transalp]

Go morgen.. ja det satser vi på, kuling med vandret regn i Nordjylland idag..

[bibob]

FDA lifts hold on Cellectis allogeneic CAR-T therapi UCARTCS1 in Multiple Myeloma

[bibob]

https://beta.firstwordpharma.com/story/5156481?t=eyJhbGciOiJBMjU2S1ciLCJlbmMiOiJBMjU2Q0JDLUhTNTEyIiwiemlwIjoiREVGIn0.gmuRo1KW9QgxjKWgjadFiBL5ruQ3OqKis5bfxRjURZQyIZpnDq4ptViVrjSBjALev7Vs0MqhfxHxHp6nVIytuOuWtBoFi-7K.9TaTpmNJc2bZSWdsJaa8Ew.i9874vuvH5jURWJIG3tpXc_eMTAtxlRVfjM7F_pcU3bw0ITNdI8C0l--fenNpk1ooD0XjMaEbuIRJQAqDUW1DQwb5OIlc7CwMaPQa0RQ5-9ZYqyA6AxR98icA-zqnHoZ_qxidX7w0bZLQ7DcWhe3qvCpLJYR_5SN6GGAotVtG8s7BBphlRtedLyUy8oyE8wQ.UO35WwwKzdnw6yEcyu_sn4VkB0JvKI1em8IspXSWwBE&nle=8172&nlc=65

[GeorgeBest]

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Genmab (NASDAQ:GMAB) A/S on Thursday, setting a price target of $45

[GeorgeBest]

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease https://ceo.ca/@newswire/immunoprecise-and-genmab-enter-into-a-technology-partnership

[E_L]

bit of a vague press release. Wondering if it has anything to do with this -27/9 07:54
af E L
I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" (link)

[deleted-user]

@E L the link is broken

[deleted-user]

And by the way you soon need a 3rd hand when counting GEN1046 expansion

[Sukkeralf]

I think so E L

[E_L]

@LLI at the time it linked to an open job
postion Genmab had. The position is not there anymore (so either filled or pulled)

[deleted-user]

Thx

[peter12]

Regarding ImmunoPrecise couldn't it be one of the CV19 collaborations Jan mentioned in the FT chat ? They live together in the Utrecht science park